High-throughput single-сell sequencing in cancer research

Signal Transduct Target Ther. 2022 May 3;7(1):145. doi: 10.1038/s41392-022-00990-4.

Abstract

With advances in sequencing and instrument technology, bioinformatics analysis is being applied to batches of massive cells at single-cell resolution. High-throughput single-cell sequencing can be utilized for multi-omics characterization of tumor cells, stromal cells or infiltrated immune cells to evaluate tumor progression, responses to environmental perturbations, heterogeneous composition of the tumor microenvironment, and complex intercellular interactions between these factors. Particularly, single-cell sequencing of T cell receptors, alone or in combination with single-cell RNA sequencing, is useful in the fields of tumor immunology and immunotherapy. Clinical insights obtained from single-cell analysis are critically important for exploring the biomarkers of disease progression or antitumor treatment, as well as for guiding precise clinical decision-making for patients with malignant tumors. In this review, we summarize the clinical applications of single-cell sequencing in the fields of tumor cell evolution, tumor immunology, and tumor immunotherapy. Additionally, we analyze the tumor cell response to antitumor treatment, heterogeneity of the tumor microenvironment, and response or resistance to immune checkpoint immunotherapy. The limitations of single-cell analysis in cancer research are also discussed.

Publication types

  • Review

MeSH terms

  • High-Throughput Nucleotide Sequencing*
  • Humans
  • Immunologic Factors
  • Immunotherapy
  • Neoplasms* / genetics
  • Neoplasms* / pathology
  • Neoplasms* / therapy
  • Single-Cell Analysis
  • Tumor Microenvironment / genetics

Substances

  • Immunologic Factors